Kon Soichiro, Konta Tsuneo, Ichikawa Kazunobu, Asahi Koichi, Yamagata Kunihiro, Fujimoto Shouichi, Tsuruya Kazuhiko, Narita Ichiei, Kasahara Masato, Shibagaki Yugo, Iseki Kunitoshi, Moriyama Toshiki, Kondo Masahide, Watanabe Tsuyoshi
Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
Steering Committee of Research on Design of the Comprehensive Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk Assessment by Specific Health Check, Fukushima, Japan.
Clin Exp Nephrol. 2018 Apr;22(2):346-352. doi: 10.1007/s10157-017-1455-0. Epub 2017 Jul 25.
Chronic kidney disease is a significant risk factor for end-stage kidney disease, cardiovascular events, and premature death. However, the prognostic value of low estimated glomerular filtration rate (eGFR) in the elderly is debatable.
We determined eGFR using the Japanese equation in 132,160 elderly subjects (65-75 years) who attended the special health checkup (Tokutei-Kenshin) in 2008 and investigated the association between baseline eGFR and 5-year all-cause and cardiovascular mortality.
The median (SD) eGFR was 70.5 ± 15.3 mL/min/1.73 m. During follow-up, we noted 2045 all-cause deaths including 408 from cardiovascular events. A J-shaped curve was obtained when all-cause and cardiovascular mortality rates were compared with decreases in eGFR, with the highest mortality observed for eGFR <45 mL/min/1.73 m. These trends were statistically significant in the Kaplan-Meier analysis (P < 0.001). In the Cox proportional hazard analysis, after adjusting for possible confounders, those with eGFR <45 mL/min/1.73 m, but not eGFR 45-59 mL/min/1.73 m showed a higher all-cause and cardiovascular mortality than those with eGFR >90 mL/min/1.73 m [hazard ratio (HR) 1.43, 95% confidence interval (CI) 1.06-1.91 for all-cause mortality, HR 2.28, 95% CI 1.28-4.03 for cardiovascular mortality]. Sex-based subgroup analyses showed similar results for both men and women.
We conclude that eGFR <45 mL/min/1.73 m is an independent risk factor for all-cause and cardiovascular mortality in the elderly population.
慢性肾脏病是终末期肾病、心血管事件和过早死亡的重要危险因素。然而,低估算肾小球滤过率(eGFR)在老年人中的预后价值存在争议。
我们使用日本方程对2008年参加特殊健康检查(特定健诊)的132160名65至75岁老年人测定eGFR,并研究基线eGFR与5年全因死亡率和心血管死亡率之间的关联。
eGFR的中位数(标准差)为70.5±15.3ml/min/1.73m²。随访期间,我们记录了2045例全因死亡,其中408例死于心血管事件。当将全因死亡率和心血管死亡率与eGFR降低进行比较时,得到一条J形曲线,eGFR<45ml/min/1.73m²时死亡率最高。这些趋势在Kaplan-Meier分析中具有统计学意义(P<0.001)。在Cox比例风险分析中,在调整可能的混杂因素后,eGFR<45ml/min/1.73m²的人群,而非eGFR为45-59ml/min/1.73m²的人群,与eGFR>90ml/min/1.73m²的人群相比,全因死亡率和心血管死亡率更高[全因死亡率的风险比(HR)为1.43,95%置信区间(CI)为1.06-1.91;心血管死亡率的HR为2.28,95%CI为1.28-4.03]。基于性别的亚组分析显示,男性和女性的结果相似。
我们得出结论,eGFR<45ml/min/1.73m²是老年人群全因死亡率和心血管死亡率的独立危险因素。